Read + Share
Amedeo Smart
Independent Medical Education
Neuen BL, Solomon SD. Kidney and Cardiovascular Outcomes With SGLT2 Inhibitors and/or GLP-1 Receptor Agonists in Type 2 Diabetes. J Am Coll Cardiol 2024;84:709-711.PMID: 39142724
Email
LinkedIn
Privacy Policy